In vivo experiments indicated that Remodelin coupled with anti-CTLA-four therapy experienced a outstanding therapeutic result compared with either treatment alone. In the long run, we confirmed the expression of NAT10 exhibited a good correlation While using the expression of PD-L1 in a variety of different types of tumors, serving as an indicator